Researchers have identified a hidden function within a gene previously thought to be well-understood in the tuberculosis bacterium. A team led by biochemist Luiz Pedro Carvalho at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology discovered that the gene known as rv2531c serves an unexpected, critical biological role.
For years, scientists assumed this gene helped build polyamines for protein production. The new findings show the gene actually encodes an enzyme that transforms glutamate into GABA, a substance essential for bacterial metabolism, signaling, and defense. This enzyme remains dormant under normal conditions but activates rapidly when the bacteria encounter stress.
This discovery is significant because it challenges long-standing assumptions about TB genetics. By revealing that the enzyme converts glutamate to GABA at a high speed when triggered, the research provides a new potential target for drug development. Given that current tuberculosis treatments are lengthy and often carry difficult side effects, identifying such metabolic vulnerabilities is a priority for researchers working to curb the disease.
Beyond tuberculosis, the study suggests that similar enzymes exist in other pathogens, including those responsible for malaria and leprosy. The researchers hope that further investigation into these pathways will lead to more effective medications. This work highlights how persistent investigation into microbial genetics can uncover biological secrets that have remained hidden for decades.